IGWM
DMRA

ICA Group Wealth Management’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

ICA Group Wealth Management’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30
Closed -$585 – 984
2024
Q1 		$585 Buy
+30
New +$533 ﹤0.01% 1285

Other funds holding DMRA

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

ICA Group Wealth Management's DMRA Position: Q2 2024 in Review

ICA Group Wealth Management sold out of Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q2 2024, closing a stake of 30 shares — an estimated $585 sold.

ICA Group Wealth Management first reported a position in DMRA in Q1 2024 and held it in 1 quarter. The position peaked at $585 in Q1 2024. 22 funds tracked by Wall St. Rank hold DMRA as of Q2 2024.

  • ICA Group Wealth Management reported no remaining Damora Therapeutics, Inc. Ordinary Shares position as of Q2 2024 after selling out during the quarter.
  • ICA Group Wealth Management sold 30 Damora Therapeutics, Inc. Ordinary Shares shares in Q2 2024, an estimated $585.
  • ICA Group Wealth Management first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q1 2024 and held it in 1 quarter.
  • ICA Group Wealth Management's Damora Therapeutics, Inc. Ordinary Shares position peaked at $585 in Q1 2024.
  • 22 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.